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Abstract: The apparently high yield of testis tumors (25%) in rats exposed long-term to 
Ochratoxin A (OTA) is uninterpretable without data on tumor yield in unexposed rats. 
Conversely, our demonstration that prenatal exposure to OTA induces DNA adducts in the 
testes of newborn mice and the absence of these adducts in the testes of mice not exposed 
prenatally to OTA, is evidence for the presumptive carcinogenicity of OTA in the testis. 
Together with recent data showing that prenatal exposure to OTA depresses expression of 
DMRT1, a tumor suppressor gene in the testis, our findings suggest that OTA may be a 
cause of testicular cancer.  
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We thank Pr. Mantle for his comments about our paper [1]. In his commentary, Pr. Mantle refers to 
perceived mis-citations of his papers. In particular, we cited his recent observation that 6/24 (25%) of 
aged Fisher rats exposed to Ochratoxin A via the diet developed testicular tumors [2]. We interpreted 
this as a priori evidence of a tumorigenic effect of Ochratoxin A on the testis, although that paper had 
no control group. We also noted his 2005 paper which also reported testicular tumors in rats exposed 
to Ochratoxin A [3]. Pr. Mantle writes in his commentary that, “it was clearly stated there [the 2005 
paper] that testis tumours occurred equally in treated rats and in controls”. However, careful review of 
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that paper with regard to testis tumors reveals only this comment: “In some older animals from both 
control and treated groups, single or multiple seminomas occurred within one or both testes (p. 61)”. 
Thus, absent data from a control group [2], and absent data on the incidence, multiplicity and histology 
of tumors from an experimental and control group [3], it would be more accurate to conclude that no 
inference about the role of Ochratoxin A in testicular tumors can be derived from the papers of 
Mantle et al. 
In contrast, our observations of DNA adducts in the testes of mice exposed prenatally to Ochratoxin 
A, and the absence of any such adducts in the testes of control mice not exposed prenatally to 
Ochratoxin A, are clear evidence of the carcinogenic potential of Ochratoxin A in the testes. The DNA 
adducts that we observed are not evidence merely of exposure (as Pr. Mantle suggests), they are 
markers of biological effect, as DNA adducts are widely considered to be markers of an increased risk 
of cancer [4–6]. Furthermore, we note that prenatal exposure to Ochratoxin A in mice significantly 
depresses expression of the DMRT1 gene in offspring, particularly male offspring [7]. DMRT1 is a 
doublesex and mab-3 related transcription factor that is expressed in Sertoli cells and undifferentiated 
spermatogonia of the postnatal testis [8]. DMRT1 is a tumor suppressor gene in the testis; loss of this 
gene produces germ cell testicular tumors in mice [9]. A large genome-wide study from the United 
Kingdom recently confirmed a role for DMRT1 in testicular germ cell tumors in humans [10]. Thus, in 
addition to our study, considerable molecular evidence supports the hypothesis that Ochratoxin A may 
be causally related to germ cell testicular tumors in mice and in men [11].  
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